Navigation Links
Upfront in Medical News

Craneware Supports Hospitals' Compliance and Upfront Collections with Accurate Estimates

Craneware's Patient Charge Estimator(TM) Gives Patients Visibility into Treatment Costs before Receiving Services ATLANTA, May 28 /PRNewswire/ -- In today's economy, with the high number of uninsured and underinsured Americans, increasingly high deductibles and co-payments, plus growth in con...

Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc

TORONTO, Oct. 26 /PRNewswire-FirstCall/ - Transition Therapeutics Inc. ("Transition") (NASDAQ: TTHI , TSX: TTH) announced the receipt of US$7.5 million representing the second half of the US$15 million upfront payment under the Company's global collaboration agreement with a subsidiary of Ela...

AMA Urges Doctors to be Upfront about Fees

The AMA will this week send education material on informed financial consent (IFC) to more than 56,000 doctors nationwide in an effort to encourage// greater openness between doctors and their patients about fees for medical care and procedures. Informed financial consent means the patient is ...

Nuvo Announces 2009 second quarter financial results

...equivalents at June 30, 2009 following receipt of the US$10 million upfront payment received from Covidien respecting its U.S. license of Penns... $14.2 million at March 31, 2009 primarily as a result of the $US10 million upfront Payment received from Covidien and proceeds from the exercise of warrants. ...

InfoLogix Selected by Hilo Medical Center for Multi-Year Engagement to Deliver 'Wireless as a Service'

...ry pre-requisite for supporting advanced EMR implementations that will be spurred by the federal government's ARRA stimulus legislation -- without the upfront costs. "We're proud to provide Hilo Medical Center with one of the most advanced and business-friendly models for achieving maximum wireless co...

BioMed Realty Trust Commemorates Five-Year Anniversary as a Public Company

...p and commercialize linaclotide, providing Ironwood pre-commercial licensing fees and milestone payments totaling $95 million, including a $40 million upfront licensing fee. On July 8, 2009, Arena Pharmaceuticals, Inc. , the company's tenth largest tenant, raised approximately $50 million in net proce...

Valeant Pharmaceuticals Reports Second Quarter Financial Results

...------- ------ ----- Accounting impact upfront payment from GSK $125,000 $- $- $- Release from upfront payment in prior quarters (20... - - 56 5,477 Release from upfront payment in current quarter (9...

MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results

...n, respectively, compared to $0 for the same periods in 2008. The collaboration revenue to date in 2009 was due to the amortization of a $40.0 million upfront payment received in February 2009 and reimbursements for UDB-related development expenses, pursuant to MAP Pharmaceuticals' license agreement with Ast...

Zepherella Enhances No Surprise Healthcare Pricing Solution for Physicians with iPhone Application

... zepherella.com. Building on the belief that healthcare pricing should be upfront and available to patients, Zepherella gives physicians a quick and convenie... zepherella.com. Building on the belief that healthcare pricing should be upfront and available to patients, Zepherella gives physicians a quick and convenie...

BioMarin Announces Second Quarter 2009 Financial Results

...o $41.4 $33.7 to $51.7 * Includes upfront research and development expenses of $8.8 million ...million in the six months ended June 30, 2008; (2) upfront license fees of $8.8 million in the six months end...4 million for 2009 and $25.3 million for 2008; (2) upfront license fees of $8.8 million associated with the R...
Upfront in Medical Technology

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...mpany's revenue will decrease when the $50 million upfront payment Isis received from Ortho-McNeil-Janssen in...me, which is primarily a result of the significant upfront payments that the Company received from its strate...sists of the timing difference associated with the upfront funding Isis received from Genzyme. Accordingly, ...

Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis

...7, BioMS entered into a licensing and development agreement granting Eli Lilly and Company exclusive worldwide rights to dirucotide in exchange for an upfront payment, milestone payments and escalating royalties on sales. For further information please visit our website at www.biomsmedical.com. This ...

Induction Chemotherapy Followed by ChemoRadiotherapy Increased Time-to-Treatment Failure Compared to ChemoRadiotherapy Alone in Patients With Unresectable Locally Advanced Head & Neck Cancer

... that Induction Chemotherapy (IC) delivered prior to standard ChemoRadiotherapy (CRT), a treatment paradigm defined as sequential therapy, compared to upfront CRT alone, significantly prolonged Time-to-Treatment Failure (TTF) for patients with unresectable Locally Advanced Head and Neck Cancer (LAHNC). The e...

Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies

...mercialisation on a worldwide basis. OBT will receive an undisclosed upfront payment and will be eligible for up to a total of $370m (GBP244m) upon the ...ent, regulatory and commercialisation milestones. In addition to the upfront and milestone payments, OBT will receive double-digit royalties on sales of...

Ironwood Announces Linaclotide European Licensing Agreement with Almirall

...ALOGO ) Under the terms of the agreement, Almirall will provide Ironwood with up to $55 million in near-term payments, including a $40 million upfront licensing fee. Pre-commercial licensing fees and milestone payments total $95 million. In addition, Ironwood will receive escalating royalties on lina...

Pharmacyclics announces Global Strategic Alliance with Les Laboratoires Servier

...on sales outside of the United States. Pharmacyclics will continue to own all rights within the United States. Pharmacyclics will receive from Servier upfront payments totaling $11 Million on signing the contract and an additional guaranteed $4 Million for research collaboration over a 24 month period, p...

Adlyfe Strikes Translational Medicine Partnership With Wyeth Pharmaceuticals for Alzheimer's Biomarker Assay

...s for specific beta amyloid targets for use in facilitating the development of treatments for Alzheimer's disease. The multiyear agreement included an upfront payment and specific future milestone payments. Further details of the agreement were not disclosed. Chief Executive Officer Alan S. Rudolph, ...

Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea

...d has already received marketing allowance from US and European regulatory authorities. Under the terms of the agreement JCOM will pay Access an upfront fee and subsequent milestone payments along with a double digit royalty upon commercialization of ProLindac and MuGard. In addition, in co-operation w...

Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV

... responsibility and associated costs for IDX899, and Idenix will receive an upfront payment of $34 million and will be eligible to receive up to $416 million i...study as part of GSK's growing drug pipeline in HIV." The $34 million upfront payment by GSK to Idenix was split evenly between cash and the purchase of ...

ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)

...-403 strategic alliance with Roche was signed in June 2008. Under the terms of this ongoing agreement, ThromboGenics and BioInvent received an initial upfront payment of EUR50 million, with the potential of milestone payments of up to EUR450 million following completion of a series of development and commerc...
Upfront in Medical Products

MD Coder Web Edition 2006

Description:...ess to the MD Coder Web Edition over the internet. The Web Edition provides the functionality and features of the Enterprise Server but leaves all the upfront costs behind. Software training, maintenance, upgrades and white glove user support are all covered in a single, flat montly fee....
Company:Mobile Design Technologies, Inc.

External CounterPulsation (ECP) Centers

Description:...ices, has assisted physicians with placing this proven cardiac treatment therapy within their office and/or diagnostic centers. We will help with the upfront investment needed to purchase equipment and our development staff will establish a turnkey facility that leaves you free to care for your patients. ...
Company:MedCath Corporation
Upfront in Biological News

NEWSLETTER: Antibody Fragment Production Breakthrough with 2nd Generation EBA

...ed Bed Adsorption (EBA) technology developed by the Danish biotech company upfront Chromatography A/S. Having conducted a series of tests, Richter-Helm has...ng in the CMO market. The Rhobust® universal processing platform from upfront Chromatography enables customers to efficiently capture and purify monoclon...

UTSA, Health Science Center collaborate with Merck & Co. to develop chlamydia vaccine

...erck license is the first revenue-producing license for any technology developed at UTSA. Upon execution of the license, Merck paid the university an upfront fee, and reimbursed UT for past patent expenses. Going forward, the license is structured to provide payments to the university as vaccine candidates...

Mass Biologic Labs/UMass Med School and Medarex license C. difficile monoclonal antibody to Merck

... MBL. Under the terms of the agreement, Merck gains worldwide rights to develop and commercialize CDA-1 and CDB-1. Medarex and MBL will receive an upfront payment of $60 million and are potentially eligible to receive additional cash payments up to $165 million upon achievement of certain milestones asso...

Rice University establishes National Corrosion Center

...Mexico, in 2000." The National Corrosion Center (NCC) intends to change the discussion on corrosion from being an afterthought to being part of the upfront decision making about an asset and its projected life, while also advancing technological solutions. "We know that you can more than double the life o...

U. Mass Medical School and Carnegie announce licensing agreements with Oxford BioMedica

... and stores its genetic information on a single-strand of RNA instead of the more usual double-stranded DNA. In exchange, Oxford BioMedica will pay an upfront payment, annual maintenance fees, milestone payments, and royalties on sales. Further details were not disclosed. James P. McNamara, PhD, Execut...

UMMS and CIW grant key RNAi rights to Oxford Biomedica

... and stores its genetic information on a single-strand of RNA instead of the more usual double-stranded DNA. In exchange, Oxford BioMedica will pay an upfront payment, annual maintenance fees, milestone payments, and royalties on sales. Further details were not disclosed. James P. McNamara, PhD, Execut...

Galapagos and Cystic Fibrosis Foundation Therapeutics announce drug discovery collaboration

...nd biotechnology industry and academia worldwide. Under the terms of the agreement, Galapagos stands to receive up to 1.6 million ($2.4 million) in upfront and research fees over the next two years, and up to 3.8 million ($5.7 million) in success-based milestone payments, should certain clinical developme...

New class of drug offers hope to treatment-resistant AIDS patients

... of Georgia, recently was licensed by Georgia biotechnology company Inhibitex from the University of Georgia Research Foundation. The license included upfront license fees and shares of the companys common stock, as well as future milestone payments and royalties. Inhibitex has also agreed to provide si...

Transfusion expert urges wider use of filtered blood

... However, Neil Blumberg, M.D., lead author of the study and a proponent of leukoreduction, argues that several cost-benefit analyses show that an upfront increase of $25 to $35 for each unit of filtered blood is offset by savings from less use of antibiotics, reduced patient time in the ICU, and shorter...

Researchers develop new method for facile identification of proteins in bacterial cells

...d Dr. Halden. "Instead of spending a lot of time and resources on eliminating the background noise to find the signal, our method increases the signal upfront so that it stands out above the background noise. By forcing an up-regulation of enzyme expression in the bacterium of interest, our target can be ide...
Upfront in Biological Technology

NeurogesX Reports Second Quarter 2009 Results

...he second quarter 2009 we strengthened our balance sheet substantially with upfront payments of approximately $48.8 million due from Astellas. Despite this sig...as included an option fee of EUR 5 million (approximately $7 million) as an upfront payment to accelerate development of NGX-1998 as part of the co-development...

Amicus Therapeutics Announces Second Quarter 2009 Financial Results

...s from the Shire agreement. Upon signing the agreement, Amicus received an upfront payment of $50 million that will be recognized as revenue on a straight-lin... In the second quarter of 2009, Amicus recognized $0.7 million of the Shire upfront payment and $4.7 million of research revenue on reimbursed research and dev...

SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS

...rterly and six month revenues in 2008 were primarily due to an $8.0 million upfront payment associated with the expansion of Senomyx's collaboration with Ajinomoto in August 2007. The upfront payment was recognized as revenue ratably over the nine month period from A...

Purdue Pharmaceutical Products L.P. and Transcept Pharmaceuticals, Inc. Sign Exclusive Agreement to Commercialize Intermezzo(R) in the United States

...ze Intermezzo ((R)) in the rest of the world. Under the terms of the agreement, Purdue will pay Transcept near-term milestones that include an upfront cash payment of $25 million and an additional payment of up to $30 million based upon the timing of an FDA approval of Intermezzo ((R)), which appr...

Endo Pharmaceuticals Reports Strong Second Quarter 2009 Financial Results

...acquisition accounting $3,648. To exclude upfront and milestone payments to partners. To exclu... To exclude separation costs. To exclude upfront and milestone payments to partners of ($4,450), se...acquisition accounting $5,267. To exclude upfront and milestone payments to partners. To exclu...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...h period relates to integration and other non-recurring items. See footnote (a). (c) This amount includes a one-time charge related to an upfront payment made with respect to the Company's execution of a co-development agreement during the quarter ended June 30, 2009, and integra...

Peregrine Pharmaceuticals Licenses Anti-VEGF Antibodies to Affitech

...ment, Affitech will be responsible for future preclinical and clinical development and potential product commercialization. Peregrine will receive an upfront payment, research fees and future milestone payments potentially totaling in the double-digit millions (US$). Peregrine will also receive royalties o...

BioMS Medical announces second quarter 2009 results

... ended June 30, 2008. This revenue is the result of the amortization of the upfront payment and development milestone payment received from Lilly, associated w...any exclusive worldwide rights to dirucotide in exchange for an $87 million upfront payment, milestone payments and escalating royalties on sales. For further ...

BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA

...ommercialize therapeutic antibodies generated through POTELLIGENT((R)) Technology for an undisclosed number of targets. In return, BioWa will receive upfront payments, and may receive development milestone payments and royalties on products. Other details of the agreement are not disclosed. About...

IKARIA(R) to In-License BioLineRx's BL-1040

...nnovations Jerusalem) incubator subsidized by the Israeli Office of the Chief Scientist. Under the terms of the agreement, BioLineRx will receive upfront and milestone payments. BioLineRx will also receive royalties on annual net sales. Ikaria will be responsible for completing clinical development and ...
Other Tags
(Date:4/17/2014)... In a review published in the April issue of ... The Feinstein Institute for Medical Research, says it,s time ... approach to treating sepsis, which kills millions ... Sepsis occurs when molecules released into the bloodstream to ... body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
(Date:4/17/2014)... Irvine, Calif., April 17, 2014 By discovering a ... immediately after a stroke, researchers at UC Irvine and ... therapies that may limit or prevent stroke-induced brain damage. ... the fourth-leading cause of death and primary reason for ... damaged in a stroke and lets blood-borne material into ...
(Date:4/17/2014)... to ward off depression among retirees, particularly among those ... The Journals of Gerontology, Series B: Psychological ... " Internet Use and Depression Among Retired Older Adults ... authors report that Internet use reduced the probability of ... sample. , Late-life depression affects between 5 and ...
(Date:4/17/2014)... 2014 Meaningful long-term survival is possible for ... abdomen when treated with cytoreductive surgery with Hyperthermic ... analysis by physicians at Wake Forest Baptist Medical ... reported, single-center experience with cytoreductive surgery and HIPEC, ... analysis of 20 years, worth of patient data ...
Breaking Medicine News(10 mins):Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Study IDs new cause of brain bleeding immediately after stroke 2Health News:Internet use may cut retirees' depression 2Health News:20 years of data shows treatment technique improvement for advanced abdominal cancer 2
(Date:4/17/2014)... stem cell therapies to cure a variety of diseases ... based on cell surface markers. Researchers from the Finnish ... highly expressed in a type of stem cells derived ... an article in BioResearch Open Access , a ... article is available free on the BioResearch ...
(Date:4/17/2014)... credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories ... safer, easier, faster and cheaper. , Bacillus ... found in soils all over the world and can ... and animals. The bacteria can survive in harsh conditions ... may occur through skin contact, inhalation of spores ...
(Date:4/17/2014)... cells in bone marrow need to produce hydrogen sulfide ... according to a new study from the Center for ... Dentistry of USC. , Professor Songtao Shi, principal investigator ... produced by the cells governs the flow of calcium ... signals that results in osteogenesis, or the creation of ...
Breaking Biology News(10 mins):Pocket-sized anthrax detector aids global agriculture 2Pocket-sized anthrax detector aids global agriculture 3
Other Contents